Navigation Links
OncoGenex Pharmaceuticals Files Shelf Registration Statement
Date:6/26/2009

BOTHELL, WA and VANCOUVER, June 26 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that it has filed a shelf registration statement on Form S-3 with the US Securities and Exchange Commission and an MJDS prospectus under the multi-jurisdictional disclosure system in the Province of British Columbia.

"It is prudent for us to re-establish a three-year shelf registration statement to provide us with the flexibility to support future opportunities," said Scott Cormack, President and CEO of OncoGenex. "Our focus remains on securing a development and commercialization partner for our OGX-011 program. Based on our discussions with potential partners to date, we believe that a partner would fund most or all of the development costs for our OGX-011 program. Accordingly, we do not expect to offer at the present time securities under this shelf registration to fund our Phase 3 clinical trials for OGX-011."

OncoGenex elected to terminate its previous shelf registration statement originally filed in July 2007.

If declared effective by the SEC and the British Columbia Securities Commission, the shelf registration statement and MJDS prospectus, respectively, will permit OncoGenex Pharmaceuticals to sell, from time to time over a three year period in one or more public offerings, shares of its common stock, shares of its preferred stock, warrants to purchase its common stock or preferred stock or debt securities, or any combination of such securities, for proceeds in the aggregate amount of up to $100 million. The terms of any such future offerings, if any, and the type of equity or debt securities would be established at the time of the offering.

A shelf registration statement relating to these securities has been filed with the SEC and an MJDS prospectus has been filed with the British Columbia Securities Com
'/>"/>

SOURCE OncoGenex Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. OncoGenex Pharmaceuticals Completes Amendment to Phase 3 Special Protocol Assessment for Confirming Survival Benefit in Patients Receiving OGX-011 with First-Line Docetaxel for Metastatic Prostate Cancer
2. OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides Survival Benefit in Randomized Phase 2 Trial in Advanced Metastatic Prostate Cancer
3. OncoGenex Pharmaceuticals Announces OGX-427 Treatment Demonstrates Safety, Evidence of Declines in Circulating Tumor Cells and Reductions in Tumor Markers in a Phase 1 Cancer Trial
4. OncoGenex Pharmaceuticals to Webcast ASCO Reception on May 30, 2009
5. OncoGenex Pharmaceuticals Announces Release of Two ASCO Abstracts: Impact of OGX-011 on Survival in Randomized Phase 2 Trial and Phase 1 Safety Data for OGX-427
6. OncoGenex Pharmaceuticals Clinical Programs to be Featured in Oral Presentations at the American Society of Clinical Oncology Annual Meeting
7. OncoGenex Reports First Quarter Financial Results
8. OncoGenex Pharmaceuticals to Release First Quarter Financial Results
9. OncoGenex Receives Confirmation from FDA on the Design of a Second Phase 3 Trial Evaluating OGX-011 for the Treatment of Advanced Prostate Cancer
10. OncoGenex Pharmaceuticals Named Life Sciences Company of the Year by LifeSciences British Columbia
11. OncoGenex Reports Financial Results for Fourth Quarter and Fiscal Year 2008 and Provides Outlook for 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2014)... R.I. (Brown University) -- The discovery 30 years ago ... an explosion of nanotechnology research. Now, there appears to ... from Brown University, Shanxi University and Tsinghua University in ... atoms forms a hollow molecular cage similar to a ... boron cage structurepreviously only a matter of speculationdoes indeed ...
(Date:7/13/2014)... Dallas, TX (PRWEB) July 13, 2014 ... Silver Industryā€¯ is a professional and in-depth study on ... Global and China. , The report provides a basic ... chain structure. Global market analysis and Chinese domestic market ... trends and competitive landscape of the market. A comparison ...
(Date:7/12/2014)... York (PRWEB) July 12, 2014 ... for various reagents used in the life ... driving the life science reagents market towards ... include manufacturers and providers of life science ... Market Report: http://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html . , The ...
(Date:7/11/2014)... July 11, 2014 /PRNewswire-iReach/ -- Maxim Peptide, a website ... are used solely in scientific experiments, is currently celebrating ... in business, Maxim Peptide, which was created by the ... new and updated website that now features a special ... been updated with fascinating articles about peptide research, including ...
Breaking Biology Technology:Researchers discover boron 'buckyball' 2Researchers discover boron 'buckyball' 32014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 22014 Nano Silver Industry in Global and China Regions Development Proposals Analysis Available at DeepResearchReports.com 3Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography 2Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography 3Maxim Peptide Celebrates Second Anniversary Online with an Updated Website and Special Deals Section 2
... Neurognostics , a home-grown Milwaukee medical device company, ... the first to take advantage of Wisconsin's new tax credits ... of an investment. , ,Neurognostics oversubscribed on its $1 million ... CEO af Neurognostics. As a tech-based research and development company, ...
... produce a single venture capital deal from January through March ... , ,Venture capitalists in the state said that the lack ... the state, though it is another reminder that capital is ... Wisconsin's investments have come erratically, sometimes adding up to around ...
... enough. Researchers at the University of Wisconsin-Madison, among other ... networked computers that share tasks such as analyzing the ... Schwartz are working with the Grid Laboratory of ... system used is Condor, software developed in-house to grab ...
Cached Biology Technology:Milwaukee firm among first to use Act 255 tax credits in investor pitch 2Milwaukee firm among first to use Act 255 tax credits in investor pitch 3Milwaukee firm among first to use Act 255 tax credits in investor pitch 4Money Tree survey shows lull in Wisconsin venture capital deals 2Money Tree survey shows lull in Wisconsin venture capital deals 3
(Date:7/13/2014)... in French . ... research project, led by the Research Institute of the ... a new oral medication is showing significant progress in ... Until now, this inherited retinal disease that causes visual ... remained untreatable. The study is published today in the ...
(Date:7/13/2014)... the prospect of more effective treatments for cachexia, a ... half of all cancer patients, raising their risk of ... Many strategies have been tried to reverse the condition, ... potentially life-saving treatments, but none have had great success. ... edition of Nature , led by Bruce Spiegelman, ...
(Date:7/11/2014)... from the Wildlife Conservation Society shows that no-take ... valuable species such as lobster, conch, and fish ... nearby reef areas. , The reporttitled "Review of ... of research literature from no-take areas around the ... Dahlgren, a recognized expert in marine protected areas ...
Breaking Biology News(10 mins):MUHC researcher unveils novel treatment for a form of childhood blindness 2Antibody halts cancer-related wasting condition 2Antibody halts cancer-related wasting condition 3Belize's lobster, conch, and fish populations rebuild in no-take zones 2
... critical cellular activities in plants and animals by using ... to learn from nature, a team of Northwestern University ... Air Force Office of Scientific Research to study and ... civilian applications. The grant is part of the ...
... Marine Animal Population , Edited by David J. ... http://shop.earthscan.co.uk/ProductDetails/mcs/productID/821 , Violent confrontations on the ... the intense hunt for sponges on Floridas fragile coral ... sponges themselves. Human harvesters not only depleted the sponge ...
... elderly residents and giving them fewer sleeping pills could ... nursing home units published in the January issue of ... by the Karolinska Institutet, Sweden, analysed 2,343 reported falls ... how they related to fall risk assessments and the ...
Cached Biology News:Team of chemists receives $5 million grant to develop enzyme mimics 2Oceans Past: A Guide to Oceans Future 2Oceans Past: A Guide to Oceans Future 3Oceans Past: A Guide to Oceans Future 4Oceans Past: A Guide to Oceans Future 5Oceans Past: A Guide to Oceans Future 6Selective restraints and reduced medication could reduce nursing home falls says 4-year study 2
PCR System for increased fidelity, yield and length of PCR products. Amplifies targets up to 10 kb from human genomic DNA....
Immunogen: Heat inactivated bacterial cells of Salmonella enteriditis,paratyphi and typhimurium Storage: 4 C...
... Immunogen: Recombinant protein ... region of human ubiquilin. ... the human ubiquilin protein. ... control: 293 cells). ...
...
Biology Products: